Dr. James B. Wetmore, MD

Dr. Wetmore practices at New Hope Dialysis Center in Minneapolis, Minnesota.

Dr. Wetmore's NPI, 1467555383, was assigned on September 6, 2006. Dr. Wetmore graduated from University of Texas Southwestern Medical School at Dallas in 1997. Dr. Wetmore holds Minnesota license 56239.

Dr. Wetmore's primary practice is New Hope Dialysis Center, at 6200 Shingle Creek Pkwy, Minneapolis, MN 55430 in Hennepin County. The practice phone is (763) 537-0300.

Dr. Wetmore's primary practice is New Hope Dialysis Center in Minneapolis, Minnesota. Dr. Wetmore is also affiliated with Hennepin County Medical Center. The medical group on file is Hennepin Healthcare. Dmand AI also links Dr. Wetmore to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wetmore practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Wetmore's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Wetmore is licensed in Minnesota.

CMS data shows 168 Medicare services from Dr. Wetmore across 4 procedure codes in 2024, for 87 Medicare patients. Medicare paid $10,273 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. Wetmore in 2024. The largest group is under 65, with 45 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 67% are also on Medicaid. Their average risk score is 7.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wetmore's median patient age at 65, with 46% women.

In 2024, Dr. Wetmore wrote 571 Medicare Part D claims for 87 patients. 89% of them were for generic drugs. CMS names the drug for 431 of them, across 12 drugs with 11 or more claims each, at $42,149 in total drug cost. In 2023, CMS named 301 claims across 7 drugs.

Dr. Wetmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 145 papers to Dr. Wetmore, published from 2006 to 2025. 2021 was the busiest year, with 16. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Medicare. Dr. Wetmore has published most often in Clin J Am Soc Nephrol. Dr. Wetmore's most frequent co-authors are Edward F. Ellerbeck, MD, Charles A. Herzog, MD and Sally Kathleen Rigler, MD, MPH.

CMS Open Payments shows 48 general payments to Dr. Wetmore from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Pfizer Inc. paid the most, $10,532. It also lists 2 research payments totaling $690 in 2020.

Dr. Wetmore graduated from University of Texas Southwestern Medical School at Dallas in 1997.